Project Details
Description
Phase 2 Trial of Voyager V1 (Vesicular Stomatitis Virus Expressing NIS and Human Interferon Beta, VV1), in Combination with Cemiplimab in patients with Hepatocellular Carcinoma, Non-Small Cell Lung Cancer, Melanoma or Endometrioid Endometrial Carcinoma
| Status | Active |
|---|---|
| Effective start/end date | 4/23/20 → 4/30/25 |
Funding
- VYRIAD
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.